Danimer Scientific Inc.

0.21
-0.14 (-40.00%)
At close: Mar 18, 2025, 3:58 PM

Company Description

Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics.

It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.

The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles.

It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry.

Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.

Danimer Scientific Inc.
Danimer Scientific Inc. logo
Country United States
IPO Date May 28, 2020
Industry Chemicals - Specialty
Sector Basic Materials
Employees 257
CEO Richard N. Altice

Contact Details

Address:
140 Industrial Boulevard
Bainbridge, Georgia
United States
Website https://www.danimerscientific.com

Stock Details

Ticker Symbol DNMR
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001779020
CUSIP Number 236272100
ISIN Number US2362721001
Employer ID 84-1924518
SIC Code 2821

Key Executives

Name Position
Richard N. Altice Interim Chief Executive Officer & Director
Michael Smith Chief Operating Officer
Michael A. Hajost Chief Financial Officer
Stephen Albert Martin Esq. Corporate Secretary & Chief Legal Officer
Anthony L. Austin Chief Human Resource Officer
James Palczynski Investor Relations Officer
John A. Dowdy III Senior Vice President of Financial Planning & Analysis
Phillip D. Van Trump Chief Science & Technology Officer
Russ Zukowski Vice President of Corporate Finance
Scott C. Tuten Chief Marketing & Sustainability Officer

Latest SEC Filings

Date Type Title
Mar 18, 2025 8-K Current Report
Feb 28, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 11, 2025 8-K Current Report
Feb 10, 2025 4 Filing
Jan 21, 2025 4 Filing
Jan 17, 2025 25-NSE Filing
Jan 03, 2025 4 Filing
Dec 31, 2024 424B3 Filing
Dec 31, 2024 8-K Current Report